BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1356 related articles for article (PubMed ID: 28207975)

  • 1. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective monitoring of BK virus replication in renal transplant recipients.
    Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
    Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
    Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.
    Faguer S; Hirsch HH; Kamar N; Guilbeau-Frugier C; Ribes D; Guitard J; Esposito L; Cointault O; Modesto A; Lavit M; Mengelle C; Rostaing L
    Transpl Int; 2007 Nov; 20(11):962-9. PubMed ID: 17666021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.
    Alméras C; Vetromile F; Garrigue V; Szwarc I; Foulongne V; Mourad G
    Transpl Infect Dis; 2011 Apr; 13(2):101-8. PubMed ID: 21371220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
    Shah T; Vu D; Naraghi R; Campbell A; Min D
    Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
    Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
    Vu D; Shah T; Ansari J; Naraghi R; Min D
    Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
    Puliyanda DP; Amet N; Dhawan A; Hilo L; Radha RK; Bunnapradist S; Czer L; Martin P; Jordan S; Toyoda M
    Clin Transplant; 2006; 20(3):289-94. PubMed ID: 16824143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L; Tönshoff B; Hirsch HH;
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study.
    Sood P; Senanayake S; Sujeet K; Medipalli R; Zhu YR; Johnson CP; Hariharan S
    Transplantation; 2012 Oct; 94(8):814-21. PubMed ID: 23018881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy.
    Radtke J; Dietze N; Fischer L; Achilles EG; Li J; Scheidat S; Thaiss F; Nashan B; Koch M
    Transpl Infect Dis; 2016 Dec; 18(6):850-855. PubMed ID: 27639176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BK virus nephritis after renal transplantation.
    Hariharan S
    Kidney Int; 2006 Feb; 69(4):655-62. PubMed ID: 16395271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on the use of cidofovir for BK virus infection in renal transplantation.
    Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
    Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
    Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
    Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.